Artificial Insemination |OMICS International| Andrology-Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Artificial Insemination

Donor insemination (DI) using cryopreserved semen was legal aspects of semen donation. Final acceptance as a donor depended facilitated by the discovery in 1949 of the cryoprotective on the outcome of a freeze–thaw test on the donor’s semen — donors properties of glycerol. Subsequent work were accepted if the post-thaw analysis showed 203106 motile showed that enhanced motility recovery could be obtained in spermatozoa/ml. Final acceptance also depended on the results of a the presence of additional components such as egg yolk and number of pathology tests. Every semen sample from a donor was glycine. Artificial insemination (AI) is the deliberate introduction of semen into a female's vagina or oviduct for the purpose of achieving a pregnancy through fertilization by means other than sexual intercourse. It is the medical alternative to sexual intercourse, or natural insemination, and is a fertility treatment for humans, a common practice in the breeding of dairy cattle (see Frozen bovine semen) and pigs, and is also used in other animal breeding. (Artificial insemination and in-vitro fertilization using donor spermatozoa: a report on 15 years of experience, G.N.Clarke, H.Bourne, P.Hill, W.I.H.Johnston)
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on May, 2021